Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 649 results for: lentiviral construct

Clear keywords
Showing: 81 - 100 of 649 results

  3. pREG(R1-R3) #BGV141

    Plasmid
    #48958
    Purpose
    Retroviral Destination vector containing AttR1-AttR3 site. For use with three-way LR reaction with cDNA in entry vector and a marker in pBEG R2-L3 plasmids (module 2 and module 3 plasmids).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Type
    Empty backbone
    Use
    Retroviral
    Promoter
    CMV
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  5. pDUAL OCLN (GFP)

    Plasmid
    #86982
    Purpose
    Lentiviral expression construct encoding Occludin and GFP from separate promoters
    Depositor
    Joe Grove
    Insert
    OCLN (OCLN Human)
    Use
    Lentiviral
    Expression
    Mammalian
    Promoter
    SFFV/hPGK
    Available Since
    Feb. 28, 2017
    Availability
    Academic Institutions and Nonprofits only
    86982-plasmid-map-sequence-id-173293

    Enlarge

  6. pDUAL CLDN (GFP)

    Plasmid
    #86981
    Purpose
    Lentiviral expression construct encoding Claudin-1 and GFP from separate promoters
    Depositor
    Joe Grove
    Insert
    CLDN1 (CLDN1 Human)
    Use
    Lentiviral
    Expression
    Mammalian
    Promoter
    SFFV/hPGK
    Available Since
    Feb. 28, 2017
    Availability
    Academic Institutions and Nonprofits only
    86981-plasmid-map-sequence-id-173292

    Enlarge

  7. lentiCRISPRv2_PROX1_1+3

    Plasmid
    #121176
    Purpose
    Lentiviral construct for the expression of Cas9 protein and puromycin resistance from EFS promoter and two guide RNAs targeting for deletion PROX1 start codon sequence.
    Depositor
    Timo Otonkoski
    Insert
    Cas9-P2A-puro and U6 promoters driven expression of gRNAs
    Use
    CRISPR and Lentiviral
    Tags
    P2A-puro
    Expression
    Mammalian
    Available Since
    July 18, 2019
    Availability
    Academic Institutions and Nonprofits only
    121176-plasmid-map-sequence-id-235001

    Enlarge

  8. lentiCRISPRv2_PROX1_1+4

    Plasmid
    #121177
    Purpose
    Lentiviral construct for the expression of Cas9 protein and puromycin resistance from EFS promoter and two guide RNAs targeting for deletion PROX1 start codon sequence.
    Depositor
    Timo Otonkoski
    Insert
    Cas9-P2A-puro and U6 promoters driven expression of gRNAs
    Use
    CRISPR and Lentiviral
    Tags
    P2A-puro
    Expression
    Mammalian
    Available Since
    March 12, 2019
    Availability
    Academic Institutions and Nonprofits only
    121177-plasmid-map-sequence-id-237896

    Enlarge

  9. pBEG R2-dsRed-L3 #BGV203

    Plasmid
    #48973
    Purpose
    Supplies the selection marker (dsRed) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Insert
    dsRed
    Use
    Gateway cloning vector
    Tags
    IRES (strong)
    Promoter
    none
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  10. pBEG R2-iBlast-L3 #BGV204

    Plasmid
    #48982
    Purpose
    Supplies the selection marker (blasticidin resistance) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Insert
    blasticidin-S deaminase
    Use
    Gateway cloning vector
    Tags
    IRES (weak)
    Promoter
    na
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  12. pBEG R2-iHygro-L3 #BGV206

    Plasmid
    #48985
    Purpose
    Supplies the selection marker (hygromycin resistance) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Insert
    hygromycin phosphotransferase
    Use
    Gateway cloning vector
    Tags
    IRES (weak)
    Promoter
    na
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  13. pBEG R2-iCreT2ALuc-L3 #BGV208

    Plasmid
    #48992
    Purpose
    Supplies Cre recombinase and Luciferase and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Inserts
    cre recombinase
    Luciferase
    Use
    Luciferase; Gateway cloning vector
    Tags
    IRES (weak)
    Promoter
    Unknown
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  14. pBEG R2-iPuro-L3 #BGV205

    Plasmid
    #48987
    Purpose
    Supplies the selection marker (puromycin resistance) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Insert
    puromycin resistance
    Use
    Gateway cloning vector
    Tags
    IRES (weak)
    Promoter
    NA
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  15. pBEG R2-eGFP-L3 #BGV201

    Plasmid
    #48979
    Purpose
    Supplies the selection marker (eGFP) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Insert
    eGFP
    Use
    Gateway cloning vector
    Tags
    IRES (strong)
    Promoter
    NA
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  16. pBEG R2-iNeo-L3 #BGV207

    Plasmid
    #48986
    Purpose
    Supplies the selection marker (neomycin resistance) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Insert
    neomycin resistance
    Use
    Gateway cloning vector
    Tags
    IRES (weak)
    Promoter
    NA
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  17. pBEG R2-eCFP-L3 #BGV202

    Plasmid
    #48977
    Purpose
    Supplies the selection marker (eCFP) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Insert
    eCFP
    Use
    Gateway cloning vector
    Tags
    IRES (strong)
    Promoter
    NA
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  18. pREG(R1-R4) #BGV059

    Plasmid
    #48991
    Purpose
    Retroviral Destination vector containing AttR1-AttR4 site. Use with 4-way LR reaction with cDNA in entry vector, marker in pBEG R2-L3 plasmids and shRNA in pBEG R3-L4 plasmid (module 2,3,and 4)
    Depositor
    David Dankort
    Article
    Geiling et al PLoS One. 2013 Oct 11;8(10):e76279. doi:
    Type
    Empty backbone
    Use
    Retroviral
    Promoter
    CMV
    Available Since
    June 16, 2014
    Availability
    Academic Institutions and Nonprofits only

  19. SHC003BSD-DelGFP

    Plasmid
    #133301
    Purpose
    EGFP reporter was removed and the selection marker was modified as blasticidin in the construct of SHC003. This construct could be used for expression of a gene by lentiviral approach.
    Depositor
    Jingshi Shen
    Article
    Wang et al J Biol Chem. 2019 Dec 27;294(52):19988-1
    Type
    Empty backbone
    Use
    Lentiviral
    Expression
    Mammalian
    Available Since
    Oct. 31, 2019
    Availability
    Academic Institutions and Nonprofits only
    133301-plasmid-map-sequence-id-261688

    Enlarge

Showing: 81 - 100 of 649 results